TransMedics Group, Inc. (TMDX)

TransMedics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,452	2,093	2,577	1,970	532	541
Market Cap Growth	-6.37%	-18.80%	30.78%	270.34%	-1.57%	37.38%
Enterprise Value	4,609	2,281	2,665	1,834	464	442
Last Close Price	130.06	62.35	78.93	61.72	19.16	19.90
PE Ratio	93.40	59.01	-	-	-	-
Forward PE	69.86	56.70	-	-	-	-
PS Ratio	8.92	4.74	10.67	21.08	17.58	21.08
PB Ratio	16.52	9.15	18.78	10.52	7.84	5.20
P/TBV Ratio	17.42	9.74	20.97	10.52	7.84	5.20
P/OCF Ratio	89.11	42.88	-	-	-	-
EV/Sales Ratio	9.44	5.17	11.03	19.62	15.34	17.25
EV/EBITDA Ratio	62.19	39.83	307.71	-	-	-
EV/EBIT Ratio	87.75	60.82	5495.72	-	-	-
Debt / Equity Ratio	1.95	2.27	3.76	0.36	0.65	0.33
Debt / EBITDA Ratio	6.45	8.19	38.35	-	-	-
Asset Turnover	0.63	0.59	0.49	0.45	0.21	0.20
Inventory Turnover	4.31	3.95	2.70	1.59	0.68	0.78
Quick Ratio	8.13	7.25	8.34	9.67	4.23	11.16
Current Ratio	9.10	8.30	9.30	10.66	5.11	12.36
Return on Equity (ROE)	22.99%	19.39%	-15.42%	-28.39%	-51.49%	-36.27%
Return on Assets (ROA)	4.21%	3.10%	0.06%	-9.54%	-17.18%	-12.82%
Return on Capital (ROIC)	4.50%	3.35%	0.07%	-10.72%	-19.70%	-14.51%
Return on Capital Employed (ROCE)	6.70%	5.00%	0.10%	-	-	-
Earnings Yield	1.11%	1.70%	-0.97%	-1.84%	-8.31%	-5.32%
FCF Yield	-1.44%	-3.87%	-6.40%	-2.93%	-6.09%	-5.68%
Buyback Yield / Dilution	-11.90%	-8.30%	-10.02%	-7.02%	-11.80%	-73.91%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q